Exposure to amphetamine (AMPH) in vivo produces an enduring enhancement ('sensitization') in AMPH-stunulated smatal DA release in virro. Experiments were conducted to determine whether suiatal DA release evoked by neuronal depolarizauon is altered by AMPH pretreatment m a sunilar manner. It was found that AMPH pretreatment produced a long-lasting (at least one week) enhancement in sniatal DA release evoked by AMPH, KC1 or electrical field stimulation. In contrast, the basal rate of DA efflux was not altered by pretteannent coruhtion. A mechanism by which a single change in the uuracellular distribution of DA could enhance both AMPH-and depolarization-induced DA release is proposed In humans chronic amphetatmne (AMPH) abuse frequently results in the development of a drug-mduced psychosis (AMPH psychosis) that is clinically similar to paranoid schrzophrema (l-4). In nonhuman animals repeated treatment with AMPH produces a progressrve enhancement in the motor stimulant effects of AMPH (behavioral sensitization), and this phenomenon IS consulered an animal analogue of AMPH psychosis ($6). There has been considerable mterest, therefore, rn the neurobiological basis of behavioral sensitizatton. Research on this question has focused on mesotelencephalic dopamine (DA) systems, in part because AMPH is thought to produce many of its effects on behavior by enhancing dopaminergic acavity, especially DA release (7-9).
Exposure to amphetamine (AMPH) in vivo produces an enduring enhancement ('sensitization') in AMPH-stunulated smatal DA release in virro. Experiments were conducted to determine whether suiatal DA release evoked by neuronal depolarizauon is altered by AMPH pretreatment m a sunilar manner. It was found that AMPH pretreatment produced a long-lasting (at least one week) enhancement in sniatal DA release evoked by AMPH, KC1 or electrical field stimulation. In contrast, the basal rate of DA efflux was not altered by pretteannent coruhtion. A mechanism by which a single change in the uuracellular distribution of DA could enhance both AMPH-and depolarization-induced DA release is proposed In humans chronic amphetatmne (AMPH) abuse frequently results in the development of a drug-mduced psychosis (AMPH psychosis) that is clinically similar to paranoid schrzophrema (l-4). In nonhuman animals repeated treatment with AMPH produces a progressrve enhancement in the motor stimulant effects of AMPH (behavioral sensitization), and this phenomenon IS consulered an animal analogue of AMPH psychosis ($6). There has been considerable mterest, therefore, rn the neurobiological basis of behavioral sensitizatton. Research on this question has focused on mesotelencephalic dopamine (DA) systems, in part because AMPH is thought to produce many of its effects on behavior by enhancing dopaminergic acavity, especially DA release (7-9).
Many neural correlates of behavioral sensitizanon have been reported 11~ the hterature (5), and of particular relevance here are reports that behavioral sensitization is accompamed by an enhancement in AMPH-stimulated sniatal DA release in virro (10-12) This change in AMPHsnmulated DA release can account for a number of features of the behavioral phenomenon. For example, both behavioral sensitizahon and an increase in AMPH-stimulated suiatal DA release in vrro: (a) can be produced by a single injection of AMPH (12, cf. 13); (b) persist for a very long time following the cessation of drug treatment (10.11); and (c) are similarly influenced by how long animals are withdrawn from AMPH pretreatment (10). It has been suggested, therefore, that an enduring change III the releasability of DA may be responsible for some of the enduring changes in behavior produced by past expenence wnh AMPH (5,ll).
To narrow down the mechanism(s) by which pnor AMPH treatment enhances striatal DA release it is important to determine if the effect is specific to AMPH-stimulated DA release, or whether the DA 3 To whom correspondence and reprint requests should be addressed 0024-3205/88 $3.00 + .OO Copyright (c) 1988 Pergamon Press plc release produced by neuronal depolanzanon is changed m a sn~~lar manner This is because DA release stnnulated by AMPH is due to a tierent process than the neuronansrmtter release associated with impulse flow and the depolarization of axonal terminals (9) Depolarizanon-mduced DA release is thought to occur by Ca*-dependent exocytosis, whereas AMPH-snmulated DA release is thought to occur by a Ca++-independent exchange-diffusion process mvolvmg the DA reuptake carrier (9, 14) To address this quesaon experiments were conducted usmg an rn vitro superfusion technique to determine the effects of AMPH pretreatment on endogenous smatal DA release elicited by either (a) AMPH, (b) KC1 depolarization; or (c) depolsrizauon by elecmcal field shmulation.
Methods

Subjects and Surgrcal Preparahon
Adult female Holtzman rats (Holtzman Co., M&son, WI) were housed mdtvldually with food and water freely available. The colony room was temperature regulated and lights were mamtamed on a 14:lO hr hght.dark cycle (lights on at 08:OO hr). Seven to 14 days before the start of an experiment animals were ovanectomized under ether anesthesia Ovanectormzed female rats were used for the followmg reasons: (a) female rats show more robust behavioral sensmzaoon than do males (15. 16); and (b) ovanectomy elnmnates the vananon in smataI DA release associated with hormonal fluctuanons across the estrous cycle (17) , but has no effect on sensmzanon (16, 18) 
Quannfication of Behavior
After each pretreatment inJection of AMPH or saline animals were nnmediately replaced mto their home cage and behavior quantified by duect visual observation and rating of stereotyped behavior. Animals were rated during a 1 mm observation period every 20 mm following the mJection, for a total of 3 hr. Overall stereotyped behavior was rated with a scale adapted from MacLennan and Mater (19) . Individual components of stereotyped behavior (1 e., smffmg, repetmve head and hmb movements and oral behaviors) were rated as described by Rebec and Segal (20) . A dady cumulanve score for each rating scale was calculated by summmg the ratings obtamed during each test session. In addition, the total volume of water mgested over 5 hr followmg each inJechon was recorded.
In Vitro DA Release One week after the last pretreatment with AMPH each rat was lalled by decapitation, and the bram was quickly removed and placed mto ice-cold medmm Coronal sections were obtained using a cutting block s~rmlar to that described by Heffner, Hartman and Seiden (21) , and after each smatum was chopped mto 1 mm3 pteces it was placed mto a superfusion chamber. The superfusion chambers and methods have been described previously (22) . Bnefly, the superfusion medium consisted of a m&tied Krebs-Ringer phosphate buffer with a final compositton of: 120 mM NaCl, 4.8 mM KCl, 1.25 mM CaCl2 .2H20, 15 mM MgS04, 15 mM phosphonc acid, 0.1% bovme serum albumin, 10 mM glucose and pH 7.4 The medunn was oxygenated with 95% 02 * 5% CO2 for 15 min and shrred continuously throughout the expenment Superfusion chambers were mamtamed at 34'C. and medium was pumped through the chambers at 100 @/mm After tissue was placed into a superfusion chamber it was left to eqtuhbrate for 65 mm before begmning sample collection. Samples were then collected over 5-min mtervals in ice-chdled tubes contaunng 25 pl of 0.5 N HC104 with dihydroxybenzylamme added as an internal standard. Samples were stored at -20" C unhl assayed by high performance liquid chromatography wtth electrochemtcal detecaon, as described previously (22) The data from each superfusion were exammed by an experienced Judge (J B.B.) who was blind to the treatment condraons, and chambers that failed to meet the followmg cntena were not considered viable and were excluded from the experiment For a chamber to be considered viable (a) shmulated DA release had to be greater than basal DA efflux (i.e., there was not a progressive decrement m DA efflux); and (b) at the end of the experiment the tissue had to respond to a 60 mM KC1 challenge by an mcrease in DA release (indicaang that the tissue was still viable) Chambers were usually excluded for reasons directly attributable to experimenter error or equipment malfunctron, and there was no group bras in the number of chambers excluded. These methods were used m all of the following experiments. and procedures specific to each experiment are described below.
Experiment 1:
The ettect ot AMPH pretreatment on AMPH-sltmulated striial DA release ln vttro: dose-response relations Ampherumlne prerreament Animals were either pretreated w-tth 3.0 mg/kg of d-AMPH sulfate (1.p.) drssolved m 0.9% saline (weight of the salt) once daly for 6 consecutive days, or left undisturbed in then home cage (non-handled). Non-handled controls were used in this experunent to mtmmize the stress-induced sensitizanon of dopammergic activity sometimes produced by repeated saline mJechons (23, 24) .
Supetfuston After the 65 mm equilibration penod (see above) 3 baseline samples were collected over 15 mm. At the beginmng of the next interval medium containing d-AMPH was mfused for either 5 mm (with 0.5,2.75 and 5.0 PM AMPH), or 2.5 mm (with 10 l.tM AMPH), and samples collected for an additional 30 min (all independent groups). Finally, 60 mM KC1 was infused for 2 5 mm and one addihonal5min
sample was collected. It should be noted that the doses of AMPH used here are lust at threshold for evokmg consistent DA release m tins apparatus, representmg the extreme far left and nonlinear pornon of the dose-response curve for AMPH-evoked striatal DA release (see Fig. 4 in ref. 22) . It was hoped that thrs would maximize the probability of detecnng an increase m the releasability of DA due to pretreatment condmon. Supe@ksron One week after the last inJection of AMPH or sahne stnatal tissue was placed into superfusron chambers as described above, except after baseline the hssue was stimulated by includmg 25,35 or 45 mM KC1 m the medmm for 5 min (the concenuanon of NaCl was reduced propomonately). The DA release evoked by these concentrations of KC1 has been previously shown to be Ca* and temperature-dependent (22) .
Electrical stlmulatlon-Induced DA release
Apparatus The top and bottom of each superfusron chamber was fitted wrth a Ag-AgCl electrode (In Vrvo Metric Systems, Healdsburg, CA). The circular surface of the top electrode had a cross-secnonal duuneter of 15 mm and the bottom electrode a diameter of 4 0 mm. The electrodes were soldered with Ag solder to lead wrres and the solder Joint reinforced wrth a conducnve Ag epoxy adhesive (Tra-Con). The electrodes were insulated with teflon heat-shnnk tubmg, except for the cross-sectional area of the up, and were separated by 12 mm (which mamtamed a 200 l,tl volume m the chambers)
Nylon mesh spacers were used to prevent tissue from restmg directly on the electrode surface Ag-AgC1 electrodes were used rather than platinum, which is frequently used for in vitro strmulanon expenments, for several reasons: (a) It has been reported that phMum acts as a catalyst for the oxrdanon of neurotransmmer substrates or of glucose, but Ag has mimmal deletenous effects on tissue vrabrhty compared to other metals (25-27), (b) Ag apparently does not affect tissue metabolism (25) , and (c) chlonded electrodes are maximally mert to physrologtcal solutions and resistant to electrolyhc processes (25.27) The electrical shmtthrs was provided by a Grass S8 snmulator and consrsted of two rectangular D.C. pulses that were passed through mdrvldual snmulus isolahon units (Crass Model SIU 478A) and m&vldual constant current umts (Crass Model CCUl A). The second pulse was delayed by the durahon of the first pulse and its polarity reversed at the constant current unit to create a true biphasrc pulse. Brphasic pulses were used to mmrrnize the tissue damage and electrode polarization sometimes associated with the use of monophasic pulses in vitro (28). Current was momtored by recording the voltage drop across a resistor located in senes with the chamber.
Pdot studtes. A series of pilot expernnents were conducted to vahdate the electrical stunulauon procedures and to determine suitable stunulus parameters. First, the intensity, pulse durauon and pulse frequency were varied to determine parameters that evoked a consistent enhancement m DA release. Second, the effect of varying the snmulus frequency (5, 10, 20, 30, 40, or 50 pulse/set, [pps]) on DA release was detenmned, while curtent (40 mA) and pulse duration (2 msec) were held constant.
The thud issue addressed in pilot studies was whether the release produced by a highly effective samulus was sensitive to calcium and temperature. Wuh electrical stunulation It is possible to produce nonselectrve neurotransrmtter release with high mtensity stimulation (29) It is difficult, however, to compare samulauon parameters from lab-to-lab because resistance varies greatly wrth such thmgs as chamber volume, the density of hSSUC. packing, and the surface area and distance between the electrodes. As pomted out by Onego (28, p 1048) it is not possible to know the actual shmulatmg current because, "most of the current that flows in the system is short clrcutted through the bulk of the hqtud" Therefore, superfusion experiments were conducted as described above, except chambers were tested wuh either: (a) normal medium at 34"C, (b) m&urn without ad&tronal Ca++ (magnesium was increased to 2.45 mM) and at 34'C, or (c) normal medmm, but at 0°C Stimulus parameters that produced a rate of DA release of approximately 200 pg DA/mg ussue/nun were used, which consisted of 40 mA, 2 msec pulses applied at 50 pps for a total of 2 mm. Behavtor was momtored only following the first and sixth mlecoon, as described above Superfusron One week after the last injection superfusion expenments were conducted as previously described,, except 20-mm frachons were collected for a total of 3 samples After one basehne sample was collected the tissue was stunulated with electrical field ShUIUlatIOn COUSlShng of brphaslc rectangular pulses (20 mA, 2 msec duration) applied for 10 set on/l0 set off for 40 nun Independent groups of chambers were shmulated at either 5, 10, or 20 pps It should be noted that the highest rate of sumulahon used in this expenment (20 pps) was ten tunes lower than used in the pilot experiment to detemune Ca++ and temperature dependence (0 8 mCoulombs/sec vs 8 mCoulombs/sec. respecnvely), and that each chamber was tested with only one frequency.
Results
Behavior.
All of the AMPH pretreatment regimens produced a slmtlar and significant enhancement m the motor stunulant effects of AMPH (1 e , behavioral sensitization) Data are shown only for Exp. 2 to illustrate typical behavioral effects (also see 15, 18, 30) . Fig 1 shows that repeated AMPH treatment produced a progressive and sigmficant enhancement m the ratmgs of overall stereotypy, stuffing and repenuve head movements, and m the amount of water ingested There was no effect of repeated AMPH treatment on oral stereotypies (data not shown), consistent with previous reports (20, 31) Experiment 1: The effect of AMPH pretreatment on AMPH-stimulated striatal DA release In vitro.
Fig 2 shows that the inclusion of AMPH in the superfusion medium enhanced endogenous smatal DA release above basal levels of DA efflux in all groups (1 e , all means are sigmficantly greater than 0). There was no effect of AMPH pretreatment on AMPH-stimulated DA release evoked by infusion of 0 5 pM or 2 75 pM AMPH for 5 nun However, mfusron of 5 PM AMPH for 5 min. or 10 @4 for 2.5 mm, produced a significantly greater increase in DA release m the AMPH pretreated group than in the control group (Fig. 2) . 3 shows that the addmon of 25 to 45 mM KC1 to the superfuslon medmm increased endogenous DA release above the basal level of DA efflux in all groups (i.e., all means are greater than 0). More Importantly, KC1 produced a greater increase in DA release m the AMPH-pretreated group than in the control group. The 2-way analysis of variance resulted in a significant main effect and no significant interaction, but mspecuon of Fig. 3 reveals a tendency for a larger Elecmcal shmulaaon sign&candy enhanced DA release above the basal levels of DA efflux 1~1 all groups (1 e., all means are greater than 0; Fig 4) There was no tiference between the salmepretreated and nonhandled control groups. and therefore they were pooled for comparison with the AMPH-pretreated group. Elecmcal snmulaaon evoked a greater change m DA release in the AMPHpretreated group than in the control group, as mQcated by a significant mam effect of pretreatment condition (Zway ANOVA) The ANOVA &d not result m a signScant uneraction, but mspecaon of Fig. 4 reveals a tendency for a greater effect at the highest stimulus frequency
I
Discussion
The AMPH pretreatment regimens used in the present expenments produced behavioral sensmzanon, as expected from previous studies (30,32-34,5 for review). Furthermore, behavioral sensitizaaon was accompamed by a dose-related enhancement m AMPH-stimulated smatal DA release in vitro, which confirms and extends previous studies (10-12). Most unportantly, AMPH pretreatment also produced an endurmg enhancement m the Ca*-dependent release of DA evoked by high KC1 or elecmcal field shmulation. These latter stu&es estabhsh that senntizatron-related changes in smatal DA release are nof unique to AMPH-samulated DA release There were no group differences in tk basal rate of DA eflux, which averaged 16.5321.06 pglmglmln across all groups. However, a 2-way analysis of variance on tk change in DA &7ux produced by elecm'cal stimulatron resulted rn a stgntficant effect of pretreatment conditron (F[I, 821 = 4.24, p =  0.04), a significant effect of stimulus frequency  (F[2, 821 = 8 95, p c 0. 
001) but no significant mteractwn
However, not all challenge doses of AMPH were effective. Smatal tissue from AMPH pretreated animals showed a greater elevation m DA release than tissue from control ammals when challenged with 5 @A AMPH for 5 min or 10 PM for 2.5 min, but not when challenged ~th lower doses (0.5 and 2 75 PM). In companson, Robmson & Becker (11) reported sensiazahon-related changes m smatal DA release when 1 w of AMF'H was infused contmuously for 10 mm. Smularly, using an mcubahon procedure, Kolta et al. (10) found that both 1@4 and 10 W AMPH were effective when applied for 15 min, although the 10 PM challenge more clearly differentiated the AMPH pretreated and control groups than &d the 1 PM challenge. In one study, a much higher dose of AMPH (1 mM) was delivered as a bnef pulse, which quickly washed out of the chamber, and this also resulted in a senntizatlon-related enhancement in smatal DA release (12) . Taken together, the avsulable evidence suggests that the ablhty of an zn vitro AMPH challenge to reveal sensitlzatlon-related changes m stnatal DA release 1s mfluenced by the duratton and concentrauon of the AMPH challenge. The effects of AMPH pretreatment on AMPH-snmulated DA release may be seen under some experimental con&nons, but not others
The effect of AMPH pretreatment on the Ca *-dependent DA release evoked by either lugh KC1 or elecmcal field sumulatlon reported here appears to be hscrepant with a previous study from this laboratory, m which it was found that KCl-evoked striatal DA release was not enhanced in sensitized rats (11) . The most probable explanation for this is an order effect. In the Robinson and Becker (11) study striatal tissue was always exposed first to AMF'H, and then to KCI. Therefore, AMPH may have depleted the amount of DA avdable for subsequent KCl-stimulated DA release It 1s thought, for example, that AMPH &splaces bound DA from storage pools (14) , which would leave less DA available for subsequent release by KCl. There was no such order effect in the present expenments. because the data are based only on the lnihal response to either AMPH, KC1 or elecmcal stunulahon.
As mennoned in the mrroduction, the process thought to metite AMPH-smnulated DA release (Ca++-Independent, tamer-medated exchange-diffusion) 1s very hfferent than that thought to me&ate DA release produced by depolanzaaon of axonal terrmnals (Ca*-dependent exocytons). Therefore, the observanon that sensmzation 1s accompanied by an enhancement of not only AMPHstunulated DA release, but also of KC1 and elecmcal shmulahon-evoked DA release, has important imphcanons for hypotheses regan%ng the neuroblolo@cal basis of the enhancement m DA release. Either the senslhzation-related enhancement in DA release 1s due to more than one mechanum, for example, one responsible for the enhancement m AMPH-samulated DA release and another for the enhancement in depohmzation-induced DA release, or, a mechanism common to both AlWH and depolarizahon-induced DA release is mvolved.
There are many neuronal adaptanons that could lead to increased DA release, but most have hfficulty accounting for changes in both depolanzanon-mduced DA release and AMPH-stunulated DA release For example, It has been suggested that the sensihzation-related enhancement m DA release and AMPH-induced behavior may be due to a subsensmvny of DA autoreceptors (35-37). But AMPH-strmulated DA release does not seem to be modulated by DA autoreceptors (38), and therefore, it is not clear how a change m DA autoreceptors could account for the sensitizanon-related enhancement in AMPH-shmulated DA release and AMPH-evoked behavior. Smularly, a role for Ca++ in AMPH sensmzauon is suggested by a report of mcreased smatal calmoduhn levels m AMPH pretreated rats (39) But AMPH-smnulated DA release is not Ca++--dependent, and therefore, it 1s not obvious how changes in Ca* mflux or a Ca++-bm&ng protem could account for changes m AMPH-stimulated DA release and AMPH-ehcrted behavror release could be due to an alteration in the reuptake carrier.
A change m AMPH-stimulated DA But the Ca*-dependent release produced by KC1 IS not affected by the presence of the DA reuptake blocker nonufensme, and this suggests that depolanzanon-induced release occurs mdependently of the uptake mechamsm (40) . Therefore, changes m the uptake mechamsm could me&ate the enhancement m AMPH-stimulated release, but presumably not the effects of AMPH pretreatment on Ca*-dependent DA release
The idea that a common mechamsm mediates the enhancement m both AMPH-stimulated and depolarization-mduced striatal DA release should be given serious consideraaon, not only because rt IS more parsunomous, but because it could also help explam the mterchangeabrhty of AMPH and stress m producing sensmzauon.
Animals sensitized to AMPH exhrbit enhanced behavtoral and neurochemical responses to subsequent swss (23, 41, 42) , and pnor stress enhances the behavroral and neurochemical responses to a subsequent AMPH challenge (23, 24, 41, (43) (44) (45) .
How could a smgle change alter the releasabthty of DA to both AMPH and depolanzanon? It 1s not due to Just an mcrease in the total amount of presynapnc DA, because AMPH pretreatment does not alter mesotelencephahc DA concentratrons (15, 18, (46) (47) (48) 5 for revrew). But it is important to consider that DA is probably located in at least 3 tiferent compartments, or 'pools', and release occurs more retiy from some pools than from others (9,49-52). A free cytoplasnuc pool is thought to contain newly synthesized DA, largely because tyrosme hydroxylase and dopadecarboxylase are not associated with synaptic vesicles (52) AMPH seems to release DA selecnvely from this pool. Metabolically older neurotransmitter is presumably bound within storage compartments, for protectron from metabohsm, until it is released by a Ca++-dependent release process. Bound pools of DA rmght correspond to vesrcular stores, and there are probably two pools of bound DA; one that IS rea&ly releasable by the arrival of an acuon potenhal at the nerve termmal ('releasable bound DA') and another that is not ('macave bound DA') The drfference between these two bound pools may be that releasable bound DA is simply closer to the neuronal membrane than the mactrve pool, and thus has greater access to release sttes (50) A redrsmbution of DA among these pools, wtth no change m total DA, could lead to an increase rn both AMPH and depolan.zahoninduced DA release m the followmg way A transfer of DA from the machve bound pool mto the releasable bound pool would obviously result m more DA redly avarlable for release upon depolanzanon of the termmal. There would be no alteranon m the size of the cytoplasmrc pool m the absence of an AMPH challenge After AlWH is taken up mto a DA terminal, however, it not only mduces DA release mto the extracellular space by exchange-diffusion, but it also dsplaces bound DA into the cytoplasm (9, 14). Thus, if AMPH pretreatment enhanced the srze of the releasable bound pool, for example, by a physical translocatron of vesicles closer to release sttes on the presynapttc membrane, then presumably they would also be closer to reuptake sites on the presynaptic membrane. AMPH that had lust entered the cytoplasm would, therefore, have access to an augmented releasable bound pool and a greater opportumty to &splace DA from this augmented releasable bound pool This would increase the amount of DA m the cytoplasnuc pool, resultmg m more DA being reruhly available for exchange&ffusron as AMPH entered the cell. In conclusion, it 1s suggested that a single change -an increase in the srze of the releasable bound pool of DA -could result m an enhancement of both AMPH and depolanzationinduced DA release This hypotheses 1s speculahve, and further research is requrred to determme the neurobiologtcal basis of the enhancement in DA release produced by AMPH pretreatment Nevertheless, the present study suggests that explorahon of presynaphc mechamsms that conconutantly regulate both uptake tamer-mediated chemical release and tmpulse-related Ca++-dependent release may provide a prormsing strategy for increasmg our understanding of the biological basis of behavioral sensmzanon In summary, it was shown that the behavioral sensitization produced by repeated intermittent injections of AMPH is accompamed by a persistent enhancement m AMPH-stimulated endogenous striatal DA release, and in Ca++-dependent DA release evoked by high KC1 or electrical stimulanon in vitro. These results support the hypothesis that an enhancement in smatal DA release may be at least partly responsible for the behavioral sensitization seen in AMPH-pretreated animals (5, 1 l), and perhaps even the hypersensmvny to the psychotogenic effects of AMPH seen in former AMPH addicts (53) (54) (55) . Of course, tlus does not exclude the possibility that changes m other neural systems are also involved (eg. 5, 23.41.45,56) .
The observation that sensitization-related changes III DA release are not unique to AMPH-stimulated DA release is also consistent with the hypothesis that behavioral sensitization is not unique to the psychopharmacology of AMPH (56) .
